Bristol-Myers Squibb Company Ce (CELG-RI) — QMA analysis
Sector: Healthcare · Data as of Nov 3, 2026
Price and market data
Bristol-Myers Squibb Company Ce has an above-average composite score of 74/100, in the top 1% of 21,574 securities in the comparison. The highest-scoring layer is Earnings quality; the lowest is Technical trend.
What 6 data layers say about CELG-RI
The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.
| Layer | Score |
|---|---|
| Fundamental value (FVS) | 78/100 |
| Earnings quality (EQS) | 100/100 |
| Technical trend (TSS) | 40/100 |
| Relative strength (RS) | 53/100 |
| Momentum (USS) | 57/100 |
| Catalysts (XS) | 84/100 |
What does the QMA model currently show for Bristol-Myers Squibb Company Ce?
The composite score is an entry point, not a signal. What matters is layer confluence — whether they point the same direction.
For CELG-RI the layers diverge — some score high (Earnings quality), others low (Technical trend). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.
CELG-RI insider & smart money activity
Over the recent period we record 12 reported insider purchases and 8 sales for CELG-RI: mixed picture. A description of the data layer, not an instruction.
CELG-RI seasonality
CELG-RI is currently in its seasonal window November 1–28 with a hit rate of 80% and an average move of 4.0% (5 years of history; selected in hindsight, descriptive, not a prediction).
Historical data does not guarantee future results.
How CELG-RI compares
Similar stocks from the same sector:
Frequently asked questions
What is the composite score for CELG-RI stock?
74/100 (grade A) as of Nov 3, 2026, fusing 6 data layers. An analytical score, not advice.
Are insiders buying CELG-RI stock?
Over the recent period, reported: purchases 12, sales 8 (purchases $99.6K, sales $268K). Insider activity: mixed picture — a description of reported data, not a trade instruction.
Where can I see live CELG-RI data?
Price and market data for CELG-RI are shown on paid plans; the QMA scores and grades on this page are free. Registration is free with no card — trial full access, then the free plan.
Explore more — for free
The CELG-RI score is just the start. Keep going free in the QMA magazine — analysis, tools and learning with no payment up front.
Want the full CELG-RI analysis with all layers and live data? Open CELG-RI detail →
Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.
⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.
Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: support@quantummarketanalyzer.com